Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston
2
×
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
roche
biopharma
cancer
cancer immunotherapy
center for medicare and medicaid services
companion diagnostic
daniel o'day
duchenne
europe blog main
europe top stories
fda
foundation medicine
foundationone cdx
foundationone heme
genentech
licensing
m&a
muscular dystrophy
new york blog main
osimertinib
rucaparib (rubraca)
san francisco blog main
sarepta therapeutics
What
billion
2
×
medicine
recently
2
×
roche
acquire
agreed
approval
betting
big
biopharma
broad
confidence
deal
didn’t
duchenne
fda
foundation
gain
gene
genentech
historic
momentum
morning
panels
pay
pays
picked
profiling
puts
redux
remaining
rest
rna
sarepta
second
share
stock
struggled
swiss
therapeutics
Language
unset
Current search:
recently
×
boston
×
billion
×
photo
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
6 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine